Navigation Links
Inovio's Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
Date:12/10/2012

d gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessmen
'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
3. Synthetic Biologics Reports Second Quarter 2012 Financial Results
4. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
5. The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC
6. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
7. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
8. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
9. Shingles Vaccine is Safe, According to New Study
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , Oct. 17, 2014  Amgen (NASDAQ: ... Sanders Williams , M.D., president of Gladstone Institutes and ... "We are pleased to welcome Dr. ... Robert A. Bradway , chairman and chief executive ... in academic medicine and his direct experience in our ...
(Date:10/17/2014)... , October 17, 2014 ... Imaging Market by Technique (Optical Coherence Tomography, ... software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) - ... report studies the Optical Imaging market over ... was valued at $917.1 million in 2014 ...
(Date:10/17/2014)... BALTIMORE, Md. , Oct. 17, 2014 /PRNewswire-USNewswire/ ... Center for Medical Technology Policy: The ... from the FDA, public and private payers, medical ... representatives, clinicians, and other experts January 12, 2015 ... effectiveness and value of weight loss treatments.  Participants ...
Breaking Medicine Technology:Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2
(Date:10/20/2014)... T.E.N., a technology and information ... that William H. Murray, renowned author and industry ... Leadership Award winner. Presented annually, the ISE® Luminary ... leader and industry practitioner for his or her ... information security industry. , Formerly with IBM, Murray ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive ... a platform to think outside the bra. She doesn’t try ... to raise awareness about women’s other lady parts. , "We ... say the color pink and everybody knows what you’re talking ... that it has not been won when it comes to ...
(Date:10/20/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... 20, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Sit and Slim II . ... to purchase or use Sit and Slim II because it ... is promoted as weight loss product on various websites and ... market in 2010 for safety reasons, can significantly increase blood ...
(Date:10/20/2014)... Akron, OH (PRWEB) October 20, 2014 ... new Assisted Living Center on Oct. 14. The $11 ... amenities and services, and a cooked-to-order kitchen with full-service ... forward Akron’s premier choice for first class Assisted Living ... groundbreaking. “Our residents deserve the highest quality of care ...
Breaking Medicine News(10 mins):Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2
... day in health-related lost productivity equals 56 cents per share ... 8 /PRNewswire/ -- In today,s challenging economy every ... for business success. To help companies make the business case ... a DVD about the experience of a Fortune 500 company ...
... Blue Cross and Blue Shield of Georgia,(BCBSGa) today announced ... more than 996 not-for-profit organizations in 2009 as part,of the ... of Georgia Foundation will match 50 percent of associate pledges,increasing ... "Every day our associates work to ...
... The end of fall marks an exciting time,for ... their,professional careers. Fellows from around the world will gather ... Interventions (SCAI),Third Annual Interventional Cardiology Fall Fellows Course in ... Given the aging population and the increasing number ...
... low risk of developing intractable disease , , MONDAY, Dec. ... giving anti-seizure medication to children with epilepsy who,ve achieved ... at high risk of later developing intractable epilepsy, a ... affects about 10 percent of children with epilepsy, is ...
... drug treatment, researchers note , , MONDAY, Dec. 8 (HealthDay ... genes of more than 40,000 people has identified 11 ... as LDL cholesterol and triglycerides. , "These locations point ... cholesterol in humans," said Dr. Sekar Kathiresan, director of ...
... Inc.,(Nasdaq: ARNA ) announced today that ... Monday, December 15, 2008, beginning at approximately 12:00 ... Jack Lief,President and Chief Executive Officer, Dominic P. ... and William R. Shanahan, M.D., Vice,President and Chief ...
Cached Medicine News:Health News:Integrated Benefits Institute Helps Employers Make the Business Case for Health and Productivity Improvement 2Health News:Blue Cross and Blue Shield of Georgia Associates Pledge More Than $1.3 Million to Community Organizations 2Health News:Blue Cross and Blue Shield of Georgia Associates Pledge More Than $1.3 Million to Community Organizations 3Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 2Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 3Health News:Seizure Meds Can Be Safely Withdrawn From Kids With Epilepsy 2Health News:11 New Cholesterol Genes Identified 2Health News:11 New Cholesterol Genes Identified 3Health News:Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008 2Health News:Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008 3
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region. The system has been approved in over 120 cases....
... Radiolucent Retractors for ... Excellent spinal exposure on ... for outstanding exposure during ... instrumentation. May be accessorized ...
... generation interbody fusion device. Rhakoss implants ... alternative to titanium/carbon fiber cages and ... the best features of first generation ... disadvantages of current available materials, such ...
As a unique complement to the spinal concepts family of products....
Medicine Products: